- Home
- VRDN vs MFIC Comparison
VRDN vs MFIC Comparison
Compare VRDN & MFIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- MFIC
- Stock Information
- Founded
- VRDN 2006
- MFIC 2004
- Country
- VRDN United States
- MFIC United States
- Employees
- VRDN N/A
- MFIC N/A
- Industry
- VRDN Medical Specialities
- MFIC Finance/Investors Services
- Sector
- VRDN Health Care
- MFIC Finance
- Exchange
- VRDN Nasdaq
- MFIC Nasdaq
- Market Cap
- VRDN 1.3B
- MFIC 1.1B
- IPO Year
- VRDN N/A
- MFIC 2004
- Fundamental
- Price
- VRDN $17.28
- MFIC $13.03
- Analyst Decision
- VRDN Strong Buy
- MFIC Buy
- Analyst Count
- VRDN 11
- MFIC 5
- Target Price
- VRDN $38.50
- MFIC $13.60
- AVG Volume (30 Days)
- VRDN 667.1K
- MFIC 307.3K
- Earning Date
- VRDN 08-07-2025
- MFIC 08-11-2025
- Dividend Yield
- VRDN N/A
- MFIC 11.68%
- EPS Growth
- VRDN N/A
- MFIC N/A
- EPS
- VRDN N/A
- MFIC 1.22
- Revenue
- VRDN $302,000.00
- MFIC $312,149,000.00
- Revenue This Year
- VRDN N/A
- MFIC $9.71
- Revenue Next Year
- VRDN $17,102.33
- MFIC $0.21
- P/E Ratio
- VRDN N/A
- MFIC $10.68
- Revenue Growth
- VRDN 4.86
- MFIC 12.66
- 52 Week Low
- VRDN $9.90
- MFIC $10.18
- 52 Week High
- VRDN $27.20
- MFIC $14.74
- Technical
- Relative Strength Index (RSI)
- VRDN 60.64
- MFIC 53.91
- Support Level
- VRDN $16.46
- MFIC $13.06
- Resistance Level
- VRDN $18.44
- MFIC $13.26
- Average True Range (ATR)
- VRDN 0.81
- MFIC 0.21
- MACD
- VRDN 0.04
- MFIC -0.01
- Stochastic Oscillator
- VRDN 57.82
- MFIC 43.53
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About MFIC MidCap Financial Investment Corporation
MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.